Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering

Biomaterials

Volumn 31, Issue 34, 2010, Pages 8911-8920

  Liao, Jiehong ^a   Guo, Xuan ^a   Grande Allen, K Jane ^a   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Bioactivity; Bioreactor; Cartilage tissue engineering; ECM (extracellular matrix); Electrospun scaffold; Mesenchymal stem cell

Indexed keywords

AGGRECAN; BIOLOGICAL SIGNALS; CAPROLACTONE; CARTILAGE TISSUE ENGINEERING; CHONDROCYTES; CHONDROGENESIS; CHONDROGENIC DIFFERENTIATION; COLLAGEN TYPE I; COMPOSITE SCAFFOLDS; DECELLULARIZATION; DYNAMIC CONDITION; ECM (EXTRACELLULAR MATRIX); ELECTROSPUNS; EXTRACELLULAR MATRICES; FLOW PERFUSION; FLOW PERFUSION BIOREACTOR; GLYCOSAMINOGLYCANS; GROWTH FACTOR; IN-VITRO; MATRIX; MATRIX COMPOSITE; MESENCHYMAL STEM CELL; MICRO-FIBER; SERUM-FREE MEDIUM; TRANSFORMING GROWTH FACTORS; TYPE II; UP-REGULATION;

BIOACTIVITY; BIOCONVERSION; BIOREACTORS; BODY FLUIDS; CARTILAGE; CELL CULTURE; COLLAGEN; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; LIGAMENTS; PEPTIDES; POLYMER MATRIX COMPOSITES; STEM CELLS; TISSUE ENGINEERING;

SCAFFOLDS;

AGGRECAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; GROWTH FACTOR; POLYCAPROLACTONE; POLYMER; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIOREACTOR; CARTILAGE; CARTILAGE CELL; CARTILAGINOUS TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FLOW PERFUSION BIOREACTOR; GENE EXPRESSION; IN VITRO STUDY; MATERIAL COATING; MESENCHYMAL STEM CELL; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SERUM; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOREACTORS; CARTILAGE; CATTLE; CELLS, CULTURED; CHONDROCYTES; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, SCANNING; PERFUSION; POLYESTERS; RHEOLOGY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77957321280     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.110     Document Type: Article

References (36)

1. Simon T.M., Jackson D.W. Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc 2006, 14(3):146-154.
2. Keeling J.J., Gwinn D.E., McGuigan F.X. A comparison of open versus arthroscopic harvesting of osteochondral autografts. Knee 2009, 16(6):458-462.
3. Brittberg M. Autologous chondrocyte implantation-technique and long-term follow-up. Injury 2008, 39(Suppl. 1):S40-S49.
4. Philp D., Chen S.S., Fitzgerald W., Orenstein J., Margolis L., Kleinman H.K. Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells 2005, 23(2):288-296.
5. Farrell E., O'Brien F.J., Doyle P., Fischer J., Yannas I., Harley B.A., et al. A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes. Tissue Eng 2006, 12(3):459-468.
6. Cheng N.C., Estes B.T., Awad H.A., Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells by a porous scaffold derived from native articular cartilage extracellular matrix. Tissue Eng Part A 2009, 15(2):231-241.
7. Li W.J., Danielson K.G., Alexander P.G., Tuan R.S. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 2003, 67(4):1105-1114.
8. Li W.J., Tuli R., Okafor C., Derfoul A., Danielson K.G., Hall D.J., et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005, 26(6):599-609.
9. Gomes M.E., Bossano C.M., Johnston C.M., Reis R.L., Mikos A.G. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 2006, 12(1):177-188.
10. Datta N., Pham Q.P., Sharma U., Sikavitsas V.I., Jansen J.A., Mikos A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A 2006, 103(8):2488-2493.
11. Liao J., Guo X., Nelson D., Kurtis Kasper F., Mikos A.G. Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. Acta Biomater 2010, 6(7):2386-2393.
12. Pham Q.P., Sharma U., Mikos A.G. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 2006, 7(10):2796-2805.
13. Bancroft G.N., Sikavitsas V.I., Mikos A.G. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng 2003, 9(3):549-554.
14. Hu J.C., Athanasiou K.A. Low-density cultures of bovine chondrocytes: effects of scaffold material and culture system. Biomaterials 2005, 26(14):2001-2012.
15. Medalie D.A., Eming S.A., Collins M.E., Tompkins R.G., Yarmush M.L., Morgan J.R. Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation 1997, 64(3):454-465.
16. Datta N., Holtorf H.L., Sikavitsas V.I., Jansen J.A., Mikos A.G. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 2005, 26(9):971-977.
17. Solchaga L.A., Gao J., Dennis J.E., Awadallah A., Lundberg M., Caplan A.I., et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002, 8(2):333-347.
18. Solchaga L.A., Johnstone B., Yoo J.U., Goldberg V.M., Caplan A.I. High variability in rabbit bone marrow-derived mesenchymal cell preparations. Cell Transplant 1999, 8(5):511-519.
19. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967, 18(2):267-273.
20. Park H., Temenoff J.S., Tabata Y., Caplan A.I., Mikos A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007, 28(21):3217-3227.
21. Pham Q.P., Kasper F.K., Scott Baggett L., Raphael R.M., Jansen J.A., Mikos A.G. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials 2008, 29(18):2729-2739.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
23. Vunjak-Novakovic G., Martin I., Obradovic B., Treppo S., Grodzinsky A.J., Langer R., et al. Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res 1999, 17(1):130-138.
24. Pazzano D., Mercier K.A., Moran J.M., Fong S.S., DiBiasio D.D., Rulfs J.X., et al. Comparison of chondrogensis in static and perfused bioreactor culture. Biotechnol Prog 2000, 16(5):893-896.
25. Freyria A.M., Yang Y., Chajra H., Rousseau C.F., Ronziere M.C., Herbage D., et al. Optimization of dynamic culture conditions: effects on biosynthetic activities of chondrocytes grown in collagen sponges. Tissue Eng 2005, 11(5-6):674-684.
26. Raimondi M.T., Moretti M., Cioffi M., Giordano C., Boschetti F., Lagana K., et al. The effect of hydrodynamic shear on 3D engineered chondrocyte systems subject to direct perfusion. Biorheology 2006, 43(3-4):215-222.
27. Heng B.C., Cao T., Lee E.H. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells 2004, 22(7):1152-1167.
28. Sobajima S., Shimer A.L., Chadderdon R.C., Kompel J.F., Kim J.S., Gilbertson L.G., et al. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J 2005, 5(1):14-23.
29. Wise J.K., Yarin A.L., Megaridis C.M., Cho M. Chondrogenic differentiation of human mesenchymal stem cells on oriented nanofibrous scaffolds: engineering the superficial zone of articular cartilage. Tissue Eng Part A 2009, 15(4):913-921.
30. Mahmood T.A., Shastri V.P., van Blitterswijk C.A., Langer R., Riesle J. Tissue engineering of bovine articular cartilage within porous poly(ether ester) copolymer scaffolds with different structures. Tissue Eng 2005, 11(7-8):1244-1253.
31. Wang L., Seshareddy K., Weiss M.L., Detamore M.S. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng Part A 2009, 15(5):1009-1017.
32. Campbell M.A., Handley C.J., Hascall V.C., Campbell R.A., Lowther D.A. Turnover of proteoglycans in cultures of bovine articular cartilage. Arch Biochem Biophys 1984, 234(1):275-289.
33. Bolis S., Handley C.J., Comper W.D. Passive loss of proteoglycan from articular cartilage explants. Biochim Biophys Acta 1989, 993(2-3):157-167.
34. von Rechenberg B., Akens M.K., Nadler D., Bittmann P., Zlinszky K., Kutter A., et al. Changes in subchondral bone in cartilage resurfacing-an experimental study in sheep using different types of osteochondral grafts. Osteoarthr Cartil 2003, 11(4):265-277.
35. Yang Z., Shi Y., Wei X., He J., Yang S., Dickson G., et al. Fabrication and characterization of a novel acellular cartilage matrix scaffold for tissue engineering. Tissue Eng Part C Methods 2009, 10.1089/ten.tec.2009.0444.
36. Elder B.D., Eleswarapu S.V., Athanasiou K.A. Extraction techniques for the decellularization of tissue engineered articular cartilage constructs. Biomaterials 2009, 30(22):3749-3756.